Productdetails
Plaats van herkomst: China
Merknaam: HBY
Certificering: COA, HPLC MR
Modelnummer: HBY-Retatrutide
Document: Productenbrochure PDF
Betaling & het Verschepen Termijnen
Min. bestelaantal: 5 dozen
Prijs: Bespreekbaar
Verpakking Details: 5/10/15 mg/injectieflacon, 10 injectieflacons/doos
Levertijd: 3 tot 5 dagen na ontvangst van de betaling
Betalingscondities: T/T, Western Union, MoneyGram
Levering vermogen: 5000 dozen per maand
Productnaam: |
Retatrutide (LY3437943) |
CAS -nummer: |
2381089-83-2 |
Synoniemen: |
LY3437943, drievoudig agonistpeptide |
Zuiverheid: |
≥ 99% (HPLC geverifieerd) |
Formulier: |
wit gevriesdroogd poeder |
Verpakking: |
Steriele, heldere glazen injectieflacon van 3 ml, vacuümverzegeld |
Moleculaire formule: |
C223H343F3N46O70 |
Molecuulgewicht: |
4731,33 g/mol |
Reeksen: |
YAibEGTFTSDYSILLLDKK(Ac)AQAibAFIEYLLEGGPSSGAPPPS |
Receptoractiviteit: |
GLP-1 / GIP / Glucagon (drievoudige agonist) |
Productnaam: |
Retatrutide (LY3437943) |
CAS -nummer: |
2381089-83-2 |
Synoniemen: |
LY3437943, drievoudig agonistpeptide |
Zuiverheid: |
≥ 99% (HPLC geverifieerd) |
Formulier: |
wit gevriesdroogd poeder |
Verpakking: |
Steriele, heldere glazen injectieflacon van 3 ml, vacuümverzegeld |
Moleculaire formule: |
C223H343F3N46O70 |
Molecuulgewicht: |
4731,33 g/mol |
Reeksen: |
YAibEGTFTSDYSILLLDKK(Ac)AQAibAFIEYLLEGGPSSGAPPPS |
Receptoractiviteit: |
GLP-1 / GIP / Glucagon (drievoudige agonist) |
Retatrutide (LY3437943) Lyophilized Powder
Research-Grade Triple Agonist Peptide | GLP-1 / GIP / GCGR
CAS: 2381089-83-2
Purity: ≥ 99% (HPLC)
Form: White lyophilized powder in 3 mL sterile vial
Sequence: YAibEGTFTSDYSILLLDKK(Ac)AQAibAFIEYLLEGGPSSGAPPPS
Molecular Formula: C₂₂₃H₃₄₃F₃N₄₆O₇₀
Molecular Weight: 4731.33 g/mol
Product Description
Retatrutide (LY3437943) is a synthetic triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors. Engineered for cutting-edge metabolic research, this once-weekly peptide demonstrates superior efficacy in glycemic control, weight reduction, and hepatic lipid metabolism compared to dual-agonist benchmarks.
Applications in Research
Storage & Handling
Legal Notice For Research Use Only (RUO). Not for human or veterinary diagnostic/therapeutic use. Not approved by FDA. Handle in accordance with institutional biosafety protocols.
